Press release
Down Syndrome Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Companies - AC Immune, Annovis Bio, Alzheon, OPKO Health, Aelis Farma, Eisai, Elixirgen, AelisFarma, Kinopharma, NeuroNascent, Pharmasum
DelveInsight's "Down Syndrome Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Down Syndrome market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The report covers emerging Down Syndrome drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Down Syndrome treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Down Syndrome: An Overview
Down syndrome is a chromosome disorder associated with intellectual disability, a characteristic facial appearance, with a small nose and an upward slant to the eyes, and low muscle tone in infancy. The degree of intellectual disability varies from mild to moderate. People with Down syndrome may also be born with various health concerns such as heart defects or digestive abnormalities, as well as short stature and a single deep crease across the center of the palm. They also have an increased risk to develop gastroesophageal reflux, celiac disease, hypothyroidism, hearing and vision problems, leukemia, and Alzheimer disease.
Down syndrome is caused by having three copies of chromosome 21 (called trisomy 21) instead of the usual two copies and is typically not inherited. Treatment focuses on the specific symptoms in each person. There is ongoing research about the specific genes causing the disease, aiming to find more effective treatments.
Down Syndrome Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Down Syndrome pipeline therapies. It also thoroughly assesses the Down Syndrome market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the market trend for each marketed Down Syndrome drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.
Discover How Down Syndrome Market Will Grow by 2032:
https://www.delveinsight.com/report-store/down-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Down Syndrome Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted Down Syndrome epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted Down Syndrome epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pools, future trends, and views of key opinion leaders.
The Report Covers the Down Syndrome Epidemiology, Segmented as -
• Gender-specific cases
• Type specific (Trisomy 21, Mosaicism and Translocation)
• Diagnosed prevalent population of Down syndrome by clinical manifestation
Get Key Insights Into the Evolving Down Syndrome Epidemiology Trends @
https://www.delveinsight.com/report-store/down-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Down Syndrome Drugs Uptake and Pipeline Development Activities
The drug uptake section focuses on the uptake rate of potential drugs recently launched in the Down Syndrome market or expected to be launched during the study period. The analysis covers the Down Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the market dynamics by drug sales, the most rapid drug uptake, and the reasons behind the maximal use of particular drugs. Additionally, it compares the Down Syndrome drugs based on their sale and market share.
The report also covers the Down Syndrome pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key Down Syndrome companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn more about the ongoing clinical and commercial development activities in the market @
https://www.delveinsight.com/sample-request/down-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Down Syndrome Therapeutics Analysis
Several major pharma and biotech companies are developing therapies for Down Syndrome. Currently, AC Immune SA is leading the therapeutics market with its Down syndrome drug candidates in the mid to advanced stage of clinical development.
Down Syndrome Companies Actively Working in the Therapeutics Market Include
• AC Immune
• Annovis Bio
• Alzheon
• OPKO Health, Inc.
• Aelis Farma
• Eisai Inc.
• Elixirgen Therapeutics
• Aphios Therapeutics
• Avanti Biosciences
• AelisFarma
• Kinopharma
• NeuroNascent, Inc.
• Pharmasum Therapeutics
And Many Others
Emerging and Marketed Down Syndrome Therapies Covered in the Report Include:
• ACI-24: AC Immune SA
• AEF0217: Aelis Farma
And Many More
The Report Covers the In-depth Assessment of the Emerging Drugs & Key Companies. Download the Sample Report to Learn More @ https://www.delveinsight.com/sample-request/down-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Down Syndrome Competitive Intelligence Analysis
4. Down Syndrome Market Overview at a Glance
5. Down Syndrome Disease Background and Overview
6. Down Syndrome Patient Journey
7. Down Syndrome Patient Population and Epidemiology Trends (In the US, EU5, and Japan)
8. Down Syndrome Treatment Algorithm, Current Treatment, and Medical Practices
9. Down Syndrome Unmet Needs
10. Key Endpoints of Down Syndrome Treatment
11. Down Syndrome Marketed Therapies
12. Down Syndrome Emerging Drugs and Latest Therapeutic Advances
13. Down Syndrome Seven Major Market Analysis
14. Attribute Analysis
15. Down Syndrome Market Outlook (In US, EU5, and Japan)
16. Down Syndrome Companies Active in the Market
17. Down Syndrome Access and Reimbursement Overview
18. KOL Views on the Down Syndrome Market
19. Down Syndrome Market Drivers
20. Down Syndrome Market Barriers
21. Appendix
22. DelveInsight Capabilities
23. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download the Sample PDF to Learn More About the Key Offerings of the Report @
https://www.delveinsight.com/sample-request/down-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Preeclampsia Market
https://www.delveinsight.com/report-store/preeclampsia-market
Chronic Periodontitis Market
https://www.delveinsight.com/report-store/chronic-periodontitis-market
Cryptococcosis Market
https://www.delveinsight.com/report-store/cryptococcosis-market
Exocrine Pancreatic Insufficiency Market
https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-market
Papilloma MarketRespiratory Distress Syndrome Market
https://www.delveinsight.com/report-store/respiratory-distress-syndrome-market
Sinusitis Market
https://www.delveinsight.com/report-store/sinusitis-market
Childhood Atropine For Myopia Progression Market
https://www.delveinsight.com/report-store/childhood-atropine-for-myopia-progression-market
Cushing's Syndrome Market
https://www.delveinsight.com/report-store/cushings-syndrome-market
Skin Burns Market
https://www.delveinsight.com/report-store/skin-burns-market
Adeno-Associated Virus Vectors in Gene Therapy Market
https://www.delveinsight.com/report-store/adeno-associated-virus-vectors-in-gene-therapy-market
Autism Spectrum Disorder Market
https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
Fragile X Syndrome (FXS) Market
https://www.delveinsight.com/report-store/fragile-x-syndrome-fxs-market
Lymphedema Market
https://www.delveinsight.com/report-store/lymphedema-market
Optic Neuropathy Market
https://www.delveinsight.com/report-store/optic-neuropathy-market
Nicotine Addiction MarketDiverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market
Sinus Dilation Devices Market
https://www.delveinsight.com/report-store/sinus-dilation-devices-market
Von Willebrand disease (VWD) Market
https://www.delveinsight.com/report-store/von-willebrand-disease-vwd-market
Type 2 Diabetes Market
https://www.delveinsight.com/report-store/type-2-diabetes-market
Bone Resorption Market
https://www.delveinsight.com/report-store/bone-resorption-market
Peptic Ulcers Market
https://www.delveinsight.com/report-store/peptic-ulcers-market
Castration-Resistant Prostate Cancer (CRPC) Market
https://www.delveinsight.com/report-store/castration-resistant-prostate-cancer-crpc-market
Dysmenorrhea Market
https://www.delveinsight.com/report-store/dysmenorrhea-market
HDAC Inhibitors Market
https://www.delveinsight.com/report-store/hdac-inhibitors-market
Iron Deficiency Anemia Market
https://www.delveinsight.com/report-store/iron-deficiency-anemia-market
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market
https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
Sacral Nerve Stimulator Devices Market
https://www.delveinsight.com/report-store/sacral-nerve-stimulator-devices-market
Graft Versus Host Disease Market
https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
Traumatic Brain Injury Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-market
Artificial Disc Market
https://www.delveinsight.com/report-store/artificial-disc-market
Corneal Endothelial Dystrophy Market
https://www.delveinsight.com/report-store/corneal-endothelial-dystrophy-market
Bone Neoplasms Market
https://www.delveinsight.com/report-store/bone-neoplasms-market
Duchenne Muscular Dystrophy Market
https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market
Secondary Hyperparathyroidism Market
https://www.delveinsight.com/report-store/secondary-hyperparathyroidism-market
Fetal Monitoring Devices Market
https://www.delveinsight.com/report-store/fetal-monitoring-devices-market
Relapsing Multiple Sclerosis (RMS) Market
https://www.delveinsight.com/report-store/relapsing-multiple-sclerosis-rms-market
Interspinous Spacers Market
https://www.delveinsight.com/report-store/interspinous-spacers-market
Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
Glioblastoma Market
https://www.delveinsight.com/report-store/glioblastoma-market
Breast Pumps Market
https://www.delveinsight.com/report-store/breast-pumps-market
Diabetic Peripheral Neuropathy Market
https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market
Throat Cancer Market
https://www.delveinsight.com/report-store/throat-cancer-market
Osteoporosis Market
https://www.delveinsight.com/report-store/osteoporosis-market
Implantable Cardioverter Defibrillators (ICDs) Market
https://www.delveinsight.com/report-store/implantable-cardioverter-defibrillators-icds-market
Open-Angle Glaucoma Market
https://www.delveinsight.com/report-store/open-angle-glaucoma-market
Atopic Dermatitis Market
https://www.delveinsight.com/report-store/atopic-dermatitis-market
Prurigo Nodularis Market
https://www.delveinsight.com/report-store/prurigo-nodularis-market
Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Down Syndrome Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Companies - AC Immune, Annovis Bio, Alzheon, OPKO Health, Aelis Farma, Eisai, Elixirgen, AelisFarma, Kinopharma, NeuroNascent, Pharmasum here
News-ID: 3173644 • Views: …
More Releases from DelveInsight Business Research LLP
Metastatic Merkel Cell Carcinoma Pipeline Outlook Report 2024 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Metastatic Merkel Cell Carcinoma pipeline constitutes 13+ key companies continuously working towards developing 15+ Metastatic Merkel Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Metastatic Merkel Cell Carcinoma pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, Metastatic Merkel…
B-Cell Lymphoma Pipeline Outlook Report 2024 (Updated)
The B-Cell Lymphoma Pipeline Insight 2024 report by DelveInsight offers a thorough global overview of B-Cell Lymphoma treatments, including those already in the market, as well as those in different phases of clinical development. Prominent pharmaceutical firms are dedicated to progressing the B-Cell Lymphoma pipeline landscape and fostering the potential growth of B-Cell Lymphoma therapeutic advancements.
Key Takeaways from the B-Cell Lymphoma Pipeline Report
• DelveInsight's B-Cell Lymphoma pipeline report depicts a…
Peanut Allergy Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Ac …
DelveInsight's, "Peanut Allergy Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in the Peanut Allergy pipeline landscape. It covers the Peanut Allergy Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Peanut Allergy Pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Epilepsy Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisit …
DelveInsight's, "Epilepsy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in the Epilepsy pipeline landscape. It covers the Epilepsy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Epilepsy Pipeline Report
• DelveInsight's Epilepsy pipeline report…
More Releases for Syndrome
Hunter Syndrome Treatment Market Size, Share | Hunter Syndrome Treatment Industr …
Global Hunter Syndrome Treatment Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Hunter Syndrome Treatment Market research report provides a point-by-point In-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain…
GBS GBS in Canada Guillain Barre Syndrome in Canada Guillain Barre Syndrome
What is Guillain-Barre Syndrome (GBS)?
Guillain-Barré (Ghee-yan Bah-ray) Syndrome is an intemperate disorder of the incidental nerves outside the brain and spinal cord.
GBS also called:
1. Acute Incendiary Demyelinating Polyneuropathy
2. Landry’s Ascending Paralysis
GBS is indicate by the rapid onset of numbness, weakness, and often paralysis of the legs, arms, breathing muscles, and face. Deflation is climbing meaning that…
Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2017, provides an overview of the Gorlin Syndrome (Basal Cell Nevus Syndrome) (Genetic Disorders) pipeline landscape.
Gorlin syndrome, also known as nevoid…
Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H1 2017
ReportsWeb.com published “Gorlin Syndrome Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Original Content:
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H1 2017, provides an overview of the Gorlin Syndrome (Basal Cell Nevus Syndrome) (Genetic Disorders) pipeline landscape.
Gorlin…
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and…
Complex Regional Pain Syndrome
“Complex Regional Pain Syndrome Global 2016 Clinical Trials Review, H2" provides an detailed overview of Complex Regional Pain Syndrome scenario.
Report includes top line data relating on Complex Regional Pain Syndrome Global clinical trials scenario.
This report on Complex Regional Pain Syndrome also includes an review of trial numbers as well as their ( Complex Regional Pain Syndrome ) average enrollment in uppermost/top countries which are conducted worldwide.
Complex Regional…
